Diagnostic Value of PET in Cardiac Sarcoidosis.
Smedema
Jan-P
JP
van Kroonenburgh
Marinus J P G
MJ
Snoep
Gabriel
G
Bekkers
Sebastian C A M
SC
Gorgels
Anton P
AP
D000328:Adult; D000368:Aged; D009202:Cardiomyopathies / Q000000981:diagnostic imaging* / Q000378:metabolism / Q000473:pathology; D002951:Citrates / Q000493:pharmacokinetics; D005260:Female; D019788:Fluorodeoxyglucose F18 / Q000493:pharmacokinetics; D005708:Gallium / Q000493:pharmacokinetics; D006321:Heart / Q000000981:diagnostic imaging; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D008875:Middle Aged; D009206:Myocardium / Q000378:metabolism; D049268:Positron-Emission Tomography / Q000379:methods; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D015203:Reproducibility of Results; D012189:Retrospective Studies; D012507:Sarcoidosis / Q000175:diagnosis / Q000000981:diagnostic imaging* / Q000378:metabolism; D012680:Sensitivity and Specificity; D013793:Thallium / Q000493:pharmacokinetics; D014018:Tissue Distribution; D014055:Tomography, Emission-Computed / Q000379:methods*
D002951:Citrates; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; C027549:thallium chloride; D013793:Thallium; D005708:Gallium; C103850:gallium citrate